Literature DB >> 27840425

JUN is a key transcriptional regulator of the unfolded protein response in acute myeloid leukemia.

C Zhou1, E Martinez1, D Di Marcantonio1, N Solanki-Patel1, T Aghayev1, S Peri1, F Ferraro1, T Skorski2, C Scholl3, S Fröhling3, S Balachandran1, D L Wiest1, S M Sykes1.   

Abstract

The transcription factor JUN is frequently overexpressed in multiple genetic subtypes of acute myeloid leukemia (AML); however, the functional role of JUN in AML is not well defined. Here we report that short hairpin RNA (shRNA)-mediated inhibition of JUN decreases AML cell survival and propagation in vivo. By performing RNA sequencing analysis, we discovered that JUN inhibition reduces the transcriptional output of the unfolded protein response (UPR), an intracellular signaling transduction network activated by endoplasmic reticulum (ER) stress. Specifically, we found that JUN is activated by MEK signaling in response to ER stress, and that JUN binds to the promoters of several key UPR effectors, such as XBP1 and ATF4, to activate their transcription and allow AML cells to properly negotiate ER stress. In addition, we observed that shRNA-mediated inhibition of XBP1 or ATF4 induces AML cell apoptosis and significantly extends disease latency in vivo tying the reduced survival mediated by JUN inhibition to the loss of pro-survival UPR signaling. These data uncover a previously unrecognized role of JUN as a regulator of the UPR as well as provide key new insights into the how ER stress responses contribute to AML and identify JUN and the UPR as promising therapeutic targets in this disease.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27840425      PMCID: PMC5473421          DOI: 10.1038/leu.2016.329

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  60 in total

1.  CHOP and AP-1 cooperatively mediate PUMA expression during lipoapoptosis.

Authors:  Sophie C Cazanave; Nafisa A Elmi; Yuko Akazawa; Steven F Bronk; Justin L Mott; Gregory J Gores
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-04-29       Impact factor: 4.052

Review 2.  Mediators of endoplasmic reticulum stress-induced apoptosis.

Authors:  Eva Szegezdi; Susan E Logue; Adrienne M Gorman; Afshin Samali
Journal:  EMBO Rep       Date:  2006-09       Impact factor: 8.807

Review 3.  Jun, the oncoprotein.

Authors:  P K Vogt
Journal:  Oncogene       Date:  2001-04-30       Impact factor: 9.867

4.  Gene expression and genetic variation in response to endoplasmic reticulum stress in human cells.

Authors:  Beth A Dombroski; Renuka R Nayak; Kathryn G Ewens; Wendy Ankener; Vivian G Cheung; Richard S Spielman
Journal:  Am J Hum Genet       Date:  2010-04-15       Impact factor: 11.025

5.  Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain.

Authors:  M Hibi; A Lin; T Smeal; A Minden; M Karin
Journal:  Genes Dev       Date:  1993-11       Impact factor: 11.361

Review 6.  Targeting inflammation by modulating the Jun/AP-1 pathway.

Authors:  Helia B Schonthaler; Juan Guinea-Viniegra; Erwin F Wagner
Journal:  Ann Rheum Dis       Date:  2011-03       Impact factor: 19.103

7.  Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9.

Authors:  Andrei V Krivtsov; David Twomey; Zhaohui Feng; Matthew C Stubbs; Yingzi Wang; Joerg Faber; Jason E Levine; Jing Wang; William C Hahn; D Gary Gilliland; Todd R Golub; Scott A Armstrong
Journal:  Nature       Date:  2006-07-16       Impact factor: 49.962

8.  XBP-1 regulates a subset of endoplasmic reticulum resident chaperone genes in the unfolded protein response.

Authors:  Ann-Hwee Lee; Neal N Iwakoshi; Laurie H Glimcher
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

9.  miR-216b regulation of c-Jun mediates GADD153/CHOP-dependent apoptosis.

Authors:  Zhenhua Xu; Yiwen Bu; Nilesh Chitnis; Costas Koumenis; Serge Y Fuchs; J Alan Diehl
Journal:  Nat Commun       Date:  2016-05-13       Impact factor: 14.919

10.  Inhibition of IRE1α-driven pro-survival pathways is a promising therapeutic application in acute myeloid leukemia.

Authors:  Haibo Sun; De-Chen Lin; Xiao Guo; Behzad Kharabi Masouleh; Sigal Gery; Qi Cao; Serhan Alkan; Takayuki Ikezoe; Chie Akiba; Ronald Paquette; Wenwen Chien; Carsten Müller-Tidow; Yang Jing; Konstantin Agelopoulos; Markus Müschen; H Phillip Koeffler
Journal:  Oncotarget       Date:  2016-04-05
View more
  21 in total

1.  Chronic myeloid leukemia stem cells require cell-autonomous pleiotrophin signaling.

Authors:  Heather A Himburg; Martina Roos; Tiancheng Fang; Yurun Zhang; Christina M Termini; Lauren Schlussel; Mindy Kim; Amara Pang; Jenny Kan; Liman Zhao; Hyung Suh; Joshua P Sasine; Gopal Sapparapu; Peter M Bowers; Gary Schiller; John P Chute
Journal:  J Clin Invest       Date:  2020-01-02       Impact factor: 14.808

2.  M2PP: a novel computational model for predicting drug-targeted pathogenic proteins.

Authors:  Shiming Wang; Jie Li; Yadong Wang
Journal:  BMC Bioinformatics       Date:  2022-01-04       Impact factor: 3.169

Review 3.  IRE1α Inhibitors as a Promising Therapeutic Strategy in Blood Malignancies.

Authors:  Wojciech Wiese; Natalia Siwecka; Adam Wawrzynkiewicz; Wioletta Rozpędek-Kamińska; Ewa Kucharska; Ireneusz Majsterek
Journal:  Cancers (Basel)       Date:  2022-05-20       Impact factor: 6.575

4.  Oncogenesis induced by combined Phf6 and Idh2 mutations through increased oncometabolites and impaired DNA repair.

Authors:  Tsung-Chih Chen; Chi-Yuan Yao; Yu-Ren Chen; Chang-Tsu Yuan; Chien-Chin Lin; Yueh-Chwen Hsu; Po-Han Chuang; Chein-Jun Kao; Yi-Hung Li; Hsin-An Hou; Wen-Chien Chou; Hwei-Fang Tien
Journal:  Oncogene       Date:  2022-01-28       Impact factor: 8.756

Review 5.  Unfolded Protein Response in Leukemia: From Basic Understanding to Therapeutic Opportunities.

Authors:  Ali Khateb; Ze'ev A Ronai
Journal:  Trends Cancer       Date:  2020-06-13

6.  The mutual regulatory loop between TPTEP1 and miR-1303 in leukemogenesis of acute myeloid leukemia.

Authors:  Li Li; Weidong Zhao
Journal:  Cancer Cell Int       Date:  2021-05-13       Impact factor: 5.722

7.  Identification of an immune classification for cervical cancer and integrative analysis of multiomics data.

Authors:  Xintong Lyu; Guang Li; Qiao Qiao
Journal:  J Transl Med       Date:  2021-05-10       Impact factor: 5.531

Review 8.  ER Stress and Unfolded Protein Response in Leukemia: Friend, Foe, or Both?

Authors:  Kelly Féral; Manon Jaud; Céline Philippe; Doriana Di Bella; Stéphane Pyronnet; Kevin Rouault-Pierre; Laurent Mazzolini; Christian Touriol
Journal:  Biomolecules       Date:  2021-01-30

9.  ATF3 coordinates serine and nucleotide metabolism to drive cell cycle progression in acute myeloid leukemia.

Authors:  Daniela Di Marcantonio; Esteban Martinez; Joice S Kanefsky; Jacklyn M Huhn; Rashid Gabbasov; Anushk Gupta; John J Krais; Suraj Peri; YinFei Tan; Tomasz Skorski; Adrienne Dorrance; Ramiro Garzon; Aaron R Goldman; Hsin-Yao Tang; Neil Johnson; Stephen M Sykes
Journal:  Mol Cell       Date:  2021-06-02       Impact factor: 19.328

10.  Somatic Mutations Drive Specific, but Reversible, Epigenetic Heterogeneity States in AML.

Authors:  Sheng Li; Xiaowen Chen; Jiahui Wang; Cem Meydan; Jacob L Glass; Alan H Shih; Ruud Delwel; Ross L Levine; Christopher E Mason; Ari M Melnick
Journal:  Cancer Discov       Date:  2020-09-16       Impact factor: 38.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.